Respiratory Distress Syndrome 1
Respiratory Distress Syndrome 1
SYNDROME
WALDEMAR A. CARLO AND NAMASIVAYAM AMBALAVANAN
CHAPTER 101.1
NELSON’S TEXTBOOK OF PEDIATRICS 20TH EDITION
PP.850-858
BARRERA, RONNEL QUILO-AN 7-2
SENIOR CLERK
DECEMBER 12, 2017
OUTLINE
SLIDE 1.1.………. DEFINITION OF RDS
SLIDE 1.2……….. INCIDENCE
SLIDE 1.3……….. RISK FACTORS
SLIDE 1.4……….. ETIOLOGY
SLIDE 1.5……….. PATHOPHYSIOLOGY
SLIDE 1.6………...CLINICAL MANIFESTATION
SLIDE 1.7………...DIAGNOSIS
SLIDE 1.8………...PREVENTION
SLIDE 1.9………...TREATMENT
SLIDE 1.10………PHARMACOLOGIC THERAPIES
SLIDE 1.11……….COMPLICATIONS
SLIDE 1.12……….PROGNOSIS
1.1.) WHAT IS RESPIRATORY DISTRESS SYNDROME ?
• PREMATURE INFANTS
60-80% < 28 WEEKS AOG
15-30% BETWEEN 32 WEEKS TO 36 WEEKS AOG
RARE 37 WEEKS AOG
HIGHEST IN PRETERM MALE OR WHITE INFANTS
1.3.) RISK FACTORS
• MATERNAL DIABETES
• MULTIPLE BIRTHS
• CESAREAN DELIVERY
• PRECIPITOUS DELIVERY
• ASPHYXIA
• COLD STRESS
• MATERNAL HISTORY OF AFFECTED OF PREVIOUSLY AFFECTED
INFANTS
1.4.) ETIOLOGY
• SURFACTANT DEFICIENCY
* LECITHIN, PHOSPATIDYLGYCEROL, APOPROTEINS (SP-A,B,C,D), CHOLESTEROL
* A.) REDUCE SURFACE TENSION
B.) MAINTAIN ALVEOLAR STABILITY BY PREVENTING THE COLLAPSE OF AIR SPACES AT
END EXPIRATION
• 20 WEEKS AOG – HIGH FETAL LUNG
• 28 TO 32 WEEKS AOG – AMNIOTIC FLUID
• 35 WEEKS AOG AND UP – MATURE LEVELS OF PULMONARY SURFACTANTS
• SURFACTANT SYNTHESIS IS INFLUENCED BY:
* NORMAL PH, TEMPERATURE, PERFUSION
• SUPPRESSES:
* ASPHYXIA, HYPOXEMIA, PULMONARY ISCHEMIA W/ HYPOVOLEMIA,
HYPOTENSION, AND COLD STRESS
LUNGS LESS COMPLIANT:
*ALVEOLAR ATELECTASIS
* HYALINE MEMBRANE FORMATION
* INTERSTITIAL EDEMA
1.5.)Pathophysiology
SOURCE:
FROM FARRELL P, ZACHMAN R: PULMONARY SURFACTANT AND THE RESPIRATORY DISTRESS SYNDROME. IN QUILLIGAN EJ, KRETCHMER N, EDITORS: FETAL AND MATERNAL
MEDICINE, NEW YORK, 1980, WILEY. REPRINTED BY PERMISSION OF JOHN WILEY AND SONS, INC.)
Source: eMedicine Medscape
1.6.) CLINICAL MANIFESTATION
IMPROVEMENT:
GRADUAL
SPONTANEOUS DIURESIS
IMPROVED BLOOD GAS VALUES
LOWER VENTILATOR SUPPORT
• DEATH:
SEVERE IMPAIRMENT OF GAS EXCHANGE
ALVEOLAR LEAKS (INTERSTITIAL EMPHYSEMA, PNEUMOTHORAX)
PULMONARY HEMORRHAGE
INTRAVENTRICULAR HEMORRHAGE
1.7.) DIAGNOSIS
• CHEST X RAY
• BLOOD GAS
• ACID BASE VALUES
CHEST X RAY:
RETICULAR GRANULARITY OF THE PARENCHYMA AND AIR
BRONCHOGRAMS,
MORE PROMINENT EARLY IN THE LOWER LOBE
DIFFERENTIAL DIAGNOSIS:
EARLY ONSET SEPSIS
PNEUMONIA
CYANOTIC HEART DISEASE
1.8.) PREVENTION
• AVOIDANCE OF POORLY TIMED EARLY CESAREAN SECTION (<39 WK) INDUCTION OF LABOR
• APPROPRIATE MANAGEMENT OF HIGH-RISK PREGNANCY AND LABOR (ADMINISTRATION OF
ANTENATAL CORTICOSTEROIDS)
• PREDICTION OF PULMONARY IMMATURITY
• ANTENATAL AND INTRAPARTUM FETAL MONITORING
• ANTENATAL CORTICOSTEROIDS TO WOMEN BEFORE 34 WK OF GESTATION
ANTENATAL STEROIDS
• SYSTEMIC CORTICOSTEROIDS
• INHALED NITRIC OXIDE
• SODIUM BICARBONATE, 1-2 MEQ/KG OVER 15-20 MIN THROUGH
A PERIPHERAL OR UMBILICAL VEIN, FOLLOWED BY ACID–BASE
DETERMINATION WITHIN 30 MIN FOR METABOLIC ACIDOSIS
• DOPAMINE IS MORE EFECTIVE IN RAISING BLOOD PRESSURE THAN
DOBUTAMINE
• EMPIRICAL ANTIBIOTIC THERAPY (PENICILLIN OR AMPICILLIN WITH
AMINOGLYCOSIDE)
• INTRAVENOUS HYDROCORTISONE AT 1-2 MG/KG/DOSE Q 6-12
HR
1.11.) COMPLICATIONS
TRACHEAL INTUBATION:
• PNEUMOTHORAX AND OTHER AIR LEAKS,
• ASPHYXIA FROM OBSTRUCTION OR DISLODGMENT OF TUBE
• BRADYCARDIA DURING INTUBATION OR SUCTIONING
• SUBSEQUENT DEVELOPMENT OF SUBGLOTTIC STENOSIS.
OTHER COMPLICATIONS
• BLEEDING FROM TRAUMA DURING INTUBATION
• POSTERIOR PHARYNGEAL PSEUDODIVERTICULA
• NEED FOR TRACHEOSTOMY
• ULCERATION OF THE NARES CAUSED BY PRESSURE FROM THE TUBE
• PERMANENT NARROWING OF THE NOSTRIL
• EROSION OF THE PALATE,
• AVULSION OF A VOCAL CORD,
• LARYNGEAL ULCER
• PAPILLOMA OF A VOCAL CORD
• ERSISTENT HOARSENESS, STRIDOR, OR EDEMA OF THE LARYNX.
• UMBILICAL ARTERIAL CATHETERIZATION
*EMBOLIZATION, THROMBOSIS, SPASM, AND VASCULAR
PERFORATION
• RENO- VASCULAR HYPERTENSION
• PATENT DUCTUS ARTERIOSUS
• BPD (BRONCHOPULMONARY DYSPLASIA)
BRONCHOPULMONARY DYSPLASIA